Author response for "Association of estimated plasma volume and weight loss after long‐term administration and subsequent discontinuation of the SGLT2 inhibitor, tofogliflozin"
Year: 2021
Type: peer-review
Source: Publons reviews and discussion
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4238317288
